Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person PTEN missense mutation that results in the substitution of a...

Class:IdSummation:2317415
_displayNamePTEN missense mutation that results in the substitution of a...
_timestamp2012-06-14 19:44:12
created[InstanceEdit:2317407] Orlic-Milacic, M, 2012-06-11
literatureReference[LiteratureReference:1889775] Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay
[LiteratureReference:2317403] Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations
[LiteratureReference:2317493] Crystal structure of human protein tyrosine phosphatase 1B
[LiteratureReference:2317505] Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association
modified[InstanceEdit:2317431] Orlic-Milacic, M, 2012-06-11
[InstanceEdit:2317491] Orlic-Milacic, M, 2012-06-12
[InstanceEdit:2317508] Orlic-Milacic, M, 2012-06-12
[InstanceEdit:2318618] Orlic-Milacic, M, 2012-06-14
textPTEN missense mutation that results in the substitution of arginine at position 130 with glutamine affects the conserved H-C-K/R-A-G-K-G-R sequence (corresponding to HCXXGXXR motif of protein tyrosine phosphatases) in the catalytic cleft of the PTEN phosphatase domain. The arginine residue in this motif, corresponding to R130 of human PTEN, is essential for catalysis (Barford et al. 1994, Lee et al. 1999). PTEN R130Q (Arg130Gln) mutant shows markedly decreased phosphoinositide phosphatase activity (Han et al. 2000). PTEN R130Q substitution is frequently found in endometrial cancer (Konopka et al. 2007).
(summation)[EntityWithAccessionedSequence:2317416] PTEN R130Q [cytosol] [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by PTEN missense mutation that results in the substitution of a... (2317415)